We are thrilled to announce that Research Lambda is officially part of the Capital Factory 2026 cohort. For us, this is rocket fuel at exactly the right moment — and we want to share what it means and where we're headed.

Why This Matters

The problem we're solving is not a small one. Clinical trial startup has been broken for decades. Sponsors lose months to manual feasibility assessments. Sites drown in surveys they never asked for. Patients wait longer than they should for treatments that already exist. Every month of delay costs sponsors an average of $1.4M in lost revenue — and more importantly, delays access to care for real people.

The platform we've built — protocol intelligence, AI site matching, feasibility automation, and study activation — is designed to compress that gap. Not marginally. Measurably. We're already seeing 15–20% faster study startup in early deployments, and we're just getting started.

"Capital Factory saw that same opportunity. And we couldn't be more excited to join a community of founders who are building things that actually matter."

What Capital Factory Gives Us

Capital Factory is one of the most active startup investors in Texas, and its network reaches deep into defense, healthcare, and enterprise technology — exactly the domains where Research Lambda operates. Their community of mentors, operators, and co-investors gives us access to knowledge and relationships that would otherwise take years to build.

For a company moving at our pace — shipping fast, signing early customers, proving out the model — this kind of institutional support accelerates everything. We can move faster. We can think bigger. And we can do it with the backing of a program that has helped launch hundreds of high-impact companies.

What's Coming Next

We're heads-down on product, growing our customer base, and building out our custom research practice for pharma and biotech organizations that need more than a platform. If you're working in clinical operations, CRO management, or study startup and want to see what we're building — our calendar is open.

To the other founders in the 2026 cohort: we can't wait to build alongside you. Austin, we're coming. 🚀

See Research Lambda in Action

Book a demo and learn how AI can cut your study startup timeline from months to days.

Book a Demo
Dr. Maksim Tsvetovat
Dr. Maksim Tsvetovat
CEO & Founder, Research Lambda